SCOPUS 정보 검색 플랫폼

Biochemical and Biophysical Research Communications

Volumn 325, Issue 2, 2004, Pages 384-387

Aβ N-terminal-end specific antibody reduced β-amyloid in Alzheimer-model mice

(6) Horikoshi, Yuko a,b Mori, Takashi c Maeda, Masahiro b Kinoshita, Noriaki b Sato, Kumiko a Yamaguchi, Haruyasu a

a GUNMA UNIVERSITY (Japan)

b Immuno Biological Laboratories Co Ltd (Japan)

c SAITAMA MEDICAL UNIVERSITY (Japan)

Author keywords

A ; Administration; Alzheimer; Antibody; APP; ELISA; Immunohistochemistry; Tg2576

Indexed keywords

AMYLOID BETA PROTEIN; MONOCLONAL ANTIBODY;

ALZHEIMER DISEASE; ANIMAL MODEL; ANTIBODY SPECIFICITY; ARTICLE; BRAIN HOMOGENATE; CONTROLLED STUDY; CROSS REACTION; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; MOUSE; NONHUMAN; PRECURSOR; PRIORITY JOURNAL; REDUCTION; ANIMAL; BASAL GANGLION; BRAIN CORTEX; CHEMISTRY; COMPARATIVE STUDY; DISEASE MODEL; DRUG ANTAGONISM; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; METABOLISM; PATHOLOGY; TRANSGENIC MOUSE; ULTRASTRUCTURE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; BASAL GANGLIA; CEREBRAL CORTEX; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MICE; MICE, TRANSGENIC;

EID: 7644225048 PISSN: 0006291X EISSN: None Source Type: Journal
DOI: 10.1016/j.bbrc.2004.10.039 Document Type: Article

Times cited : (24)

References (10)

1
- 0033536163
- Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
- D. Schenk, R. Barbour, W. Dunn, G. Gordon, H. Grajeda, T. Guido, K. Hu, J. Huang, K. Johnson-Wood, K. Khan, D. Kholodenko, M. Lee, Z. Liao, I. Lieberburg, R. Motter, L. Mutter, F. Soriano, G. Shopp, N. Vasquez, C. Vandevert, S. Walker, M. Wogulis, T. Yednock, D. Games, and P. Seubert Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse Nature 400 1999 173 177
- (1999) Nature , vol.400 , pp. 173-177
- Schenk, D.¹ Barbour, R.² Dunn, W.³ Gordon, G.⁴ Grajeda, H.⁵ Guido, T.⁶ Hu, K.⁷ Huang, J.⁸ Johnson-Wood, K.⁹ Khan, K.¹⁰ Kholodenko, D.¹¹ Lee, M.¹² Liao, Z.¹³ Lieberburg, I.¹⁴ Motter, R.¹⁵ Mutter, L.¹⁶ Soriano, F.¹⁷ Shopp, G.¹⁸ Vasquez, N.¹⁹ Vandevert, C.²⁰ more..

2
- 0037203825
- Nerve inflammation halts trial for Alzheimer's drug
- E. Check Nerve inflammation halts trial for Alzheimer's drug Nature 415 2002 462
- (2002) Nature , vol.415 , pp. 462
- Check, E.¹

3
- 0033835996
- Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease
- F. Bard, C. Cannon, R. Barbour, R.L. Burke, D. Games, H. Grajeda, T. Guido, K. Hu, J. Huang, K. Johnson-Wood, K. Khan, D. Kholodenko, M. Lee, I. Lieberburg, R. Motter, M. Nguyen, F. Soriano, N. Vasquez, K. Weiss, B. Welch, P. Seubert, D. Schenk, and T. Yednock Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease Nat. Med. 6 2000 916 919
- (2000) Nat. Med. , vol.6 , pp. 916-919
- Bard, F.¹ Cannon, C.² Barbour, R.³ Burke, R.L.⁴ Games, D.⁵ Grajeda, H.⁶ Guido, T.⁷ Hu, K.⁸ Huang, J.⁹ Johnson-Wood, K.¹⁰ Khan, K.¹¹ Kholodenko, D.¹² Lee, M.¹³ Lieberburg, I.¹⁴ Motter, R.¹⁵ Nguyen, M.¹⁶ Soriano, F.¹⁷ Vasquez, N.¹⁸ Weiss, K.¹⁹ Welch, B.²⁰ more..

4
- 0037452779
- Epitope and isotype specificities of antibodies to β-amyloid peptide for protection against Alzheimer's disease-like neuropathology
- F. Bard, R. Barbour, C. Cannon, R. Carretto, M. Fox, D. Games, T. Guido, K. Hoenow, K. Hu, K. Johnson-Wood, K. Khan, D. Kholodenko, C. Lee, M. Lee, R. Motter, M. Nguyen, A. Reed, D. Schenk, P. Tang, N. Vasquez, P. Seubert, and T. Yednock Epitope and isotype specificities of antibodies to β-amyloid peptide for protection against Alzheimer's disease-like neuropathology Proc. Natl. Acad. Sci. USA 100 2003 2023 2028
- (2003) Proc. Natl. Acad. Sci. USA , vol.100 , pp. 2023-2028
- Bard, F.¹ Barbour, R.² Cannon, C.³ Carretto, R.⁴ Fox, M.⁵ Games, D.⁶ Guido, T.⁷ Hoenow, K.⁸ Hu, K.⁹ Johnson-Wood, K.¹⁰ Khan, K.¹¹ Kholodenko, D.¹² Lee, C.¹³ Lee, M.¹⁴ Motter, R.¹⁵ Nguyen, M.¹⁶ Reed, A.¹⁷ Schenk, D.¹⁸ Tang, P.¹⁹ Vasquez, N.²⁰ Seubert, P.²¹ Yednock, T.²² more..

5
- 2942525573
- Development of Aβ terminal end-specific antibodies and sensitive ELISA for Aβ variant
- Y. Horikoshi, G. Sakaguchi, A.G. Becker, A.J. Gray, K. Duff, P.S. Aisen, H. Yamaguchi, M. Maeda, N. Kinoshita, and Y. Matsuoka Development of Aβ terminal end-specific antibodies and sensitive ELISA for Aβ variant Biochem. Biophys. Res. Commun. 319 2004 733 737
- (2004) Biochem. Biophys. Res. Commun. , vol.319 , pp. 733-737
- Horikoshi, Y.¹ Sakaguchi, G.² Becker, A.G.³ Gray, A.J.⁴ Duff, K.⁵ Aisen, P.S.⁶ Yamaguchi, H.⁷ Maeda, M.⁸ Kinoshita, N.⁹ Matsuoka, Y.¹⁰

6
- 0033635302
- Effect of apolipoprotein e allele ε4 on the initial phase of amyloid β-protein accumulation in the human brain
- M. Morishima-Kawashima, N. Oshima, H. Ogata, H. Yamaguchi, M. Yoshimura, S. Sugihara, and Y. Ihara Effect of apolipoprotein E allele ε4 on the initial phase of amyloid β-protein accumulation in the human brain Am. J. Pathol. 157 2000 2093 2099
- (2000) Am. J. Pathol. , vol.157 , pp. 2093-2099
- Morishima-Kawashima, M.¹ Oshima, N.² Ogata, H.³ Yamaguchi, H.⁴ Yoshimura, M.⁵ Sugihara, S.⁶ Ihara, Y.⁷

7
- 0035863055
- Age-dependent changes in brain, CSF, plasma amyloid β protein in the Tg2576 transgenic mouse model of Alzheimer's disease
- T. Kawarabayashi, L.H. Younkin, T.C. Saido, M. Shoji, K.H. Ashe, and S.G. Younkin Age-dependent changes in brain, CSF, plasma amyloid β protein in the Tg2576 transgenic mouse model of Alzheimer's disease J. Neurosci. 21 2001 372 381
- (2001) J. Neurosci. , vol.21 , pp. 372-381
- Kawarabayashi, T.¹ Younkin, L.H.² Saido, T.C.³ Shoji, M.⁴ Ashe, K.H.⁵ Younkin, S.G.⁶

8
- 0037107177
- Non-Fc-mediated mechanisms are involved in clearance of amyloid-β in vivo by immunotherapy
- B.J. Bacskai, S.T. Kajdasz, M.E. McLellan, D. Games, P. Seubert, D. Schenk, and B.T. Hyman Non-Fc-mediated mechanisms are involved in clearance of amyloid-β in vivo by immunotherapy J. Neurosci. 22 2002 7873 7878
- (2002) J. Neurosci. , vol.22 , pp. 7873-7878
- Bacskai, B.J.¹ Kajdasz, S.T.² McLellan, M.E.³ Games, D.⁴ Seubert, P.⁵ Schenk, D.⁶ Hyman, B.T.⁷

9
- 0037531198
- Intracranially administered anti-Aβ antibodies reduce β-amyloid deposition by mechanisms both independent of and associated with microglial activation
- D.M. Wilcock, G. DiCarlo, D. Henderson, J. Jackson, K. Clarke, K.E. Ugen, M.N. Gordon, and D. Morgan Intracranially administered anti-Aβ antibodies reduce β-amyloid deposition by mechanisms both independent of and associated with microglial activation J. Neurosci. 23 2003 3745 3751
- (2003) J. Neurosci. , vol.23 , pp. 3745-3751
- Wilcock, D.M.¹ Dicarlo, G.² Henderson, D.³ Jackson, J.⁴ Clarke, K.⁵ Ugen, K.E.⁶ Gordon, M.N.⁷ Morgan, D.⁸

10
- 0035902619
- Peripheral anti-Aβ antibody alters CNS and plasma Aβ clearance and decreases brain Aβ burden in a mouse model of Alzheimer's disease
- R.B. DeMattos, K.R. Bales, D.J. Cummins, J.-C. Dodart, S.M. Paul, and D.M. Holtzman Peripheral anti-Aβ antibody alters CNS and plasma Aβ clearance and decreases brain Aβ burden in a mouse model of Alzheimer's disease Proc. Natl. Acad. Sci. USA 98 2001 8850 8855
- (2001) Proc. Natl. Acad. Sci. USA , vol.98 , pp. 8850-8855
- Demattos, R.B.¹ Bales, K.R.² Cummins, D.J.³ Dodart, J.-C.⁴ Paul, S.M.⁵ Holtzman, D.M.⁶

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.